GET A QUOTE

LXR-Alpha (NR1H3): A Nuclear Receptor at the Crossroads of Lipid Metabolism and Inflammatory Response

Molecular Structure and Activation Mechanisms

The protein LXR alpha (NR1H3) is part of a group of receptors. Has the typical structure that includes a DNA binding domain (DBD), a ligand binding domain (LBL) and a flexible hinge region. It acts as a transcription factor activated by ligands and undergoes changes when it binds to oxysterols, its natural ligands. The LBL has a pocket that can hold oxysterols like 22(R) hydroxycholesterol 24(S) hydroxycholesterol and 27 hydroxycholesterol. When a molecule binds to the receptors site. Triggers changes, in its shape occur that help in releasing corepressors and bringing in coactivators for activating transcription processes. The DNA binding domain (DBD) of the receptor identifies codes called LXR response elements (LXREs) usually made up of repeated sequences separated by four nucleotides (DR4).

Physiological Roles in Lipid Metabolism

In the livers workings on cholesterol balance and lipid processing is governed by LXR alpha as a controller. It handles aspects of cholesterol management such, as enhancing the release of cholesterol by increasing ABC transporters (ABCA1 and ABCB1) stimulating bile acid production via CYP7A1 activation and managing fatty acid creation through SREBP-1c. The receptor is essential, in the process of reversing cholesterol transport by aiding in transporting surplus cholesterol from tissues to the liver for removal. Within macrophages LXR alpha activation boosts the ability to remove cholesterol effectively which helps in avoiding the development of foam cells and atherosclerosis buildup, in the body system. Moreover, it plays a role in managing glucose levels and insulin sensitivity which showcases its function in maintaining metabolic balance. Given its involvement in this system LXR alpha emerges as a pivotal target, for treating metabolic conditions.

Role in Disease Pathogenesis

The disruption of LXR alpha signalling has been linked to a range of health issues and diseases. In the case of atherosclerosis diminishing LXR alpha activity plays a role, in the creation of foam cells and the development of plaques. In cancer research, LXR alpha exhibits varying effects depending on the context it may either promote or inhibit tumor growth contingent upon the type of cancer and metabolic conditions present. The involvement of the receptor, in conditions has attracted interest as well. Especially in Alzheimer’s disease. As it could impact amyloid beta processing and brain inflammation management is vital, for devising solutions that focus on LXR alpha.

Therapeutic Applications and Drug Development

The exploration of medications that target LXR alpha has been a field of study, among researchers lately. There have been encouraging results with man-made LXR activators in addressing atherosclerosis and inflammatory diseases. However, some hurdles persist due to their impact, on liver fat production resulting in fatty liver and higher levels of blood triglycerides. ​New strategies involve creating LXR activators that target the intestines or developing modulators that affect both LXR and FXF functions simultaneously. Cutting edge methods of delivery and precise aiming techniques are being investigated to improve the effectiveness of treatments, for health conditions not limited to metabolic disorders but also encompass ailments and neurodegenerative diseases as well, as specific types of cancerous growths.

Transcriptional Networks and Cross-talk

The LXR alpha protein functions, within a system of switches and controllers by interacting with different nuclear receptors and regulatory proteins in the cell nucleus. It forms partnerships with RXRs. Can be influenced by other nuclear receptors such as PPARs and FXRs. The activity of this receptor is adjusted by transcriptional changes like phosphorylation, SUMOylation and acetylation that impact its stability position and gene regulatory abilities. LXR alpha is also involved in regulating metabolism through its connections, with biological clock proteins. The receptors capacity to manage pathways positions it, as a vital hub, in maintaining cellular balance and responding to stress effectively.

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford